Skip to search.
 TSX Down 0.12% TSX Ventures Up 0.41%

Incyte Corporation (INCY)

-NasdaqGS
100.96 Down 0.42(0.41%) 11:58AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:101.38
Open:101.73
Bid:100.85 x 100
Ask:100.96 x 100
1y Target Est:102.08
Beta:0.08
Next Earnings Date:30-Apr-15INCY Earnings announcement
Day's Range:97.14 - 104.01
52wk Range:43.86 - 111.93
Volume:897,907
Avg Vol (3m):1,189,200
Market Cap:17.51B
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 0.41%17.51B
AMGNUp 1.03%124.69B
CELGDown 0.65%91.24B
RHHBYDown 1.02%N/A

Key Statistics

Forward P/E (1 yr):103.96
P/S (ttm):34.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.26
Quarterly EPS Est (Mar-15) :-0.10
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-4.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback